With Two Potential First-in-class Innovative Drugs’ Commercialization around the Corner, RemeGen is Expected to Explode upon Listing
HONG KONG, Nov 6, 2020 – (ACN Newswire) – According to Bloomberg, recent years have seen the strong performance of biopharmaceutical enterprises in Hong Kong […]